CDC’s ACIP Will Reconvene April 23 To Discuss Pause On J&J’s Vaccine

The Centers for Disease Control and Prevention’s vaccine advisory committee will reconvene Friday (April 23) to discuss whether Johnson & Johnson’s COVID-19 vaccine is OK to use in the United States after vaccinations were paused in light of reports of rare but serious blood clots experienced by six people who received the shot. The meeting will be held Friday from 11 a.m. to 5 p.m. EST, according to CDC’s Advisory Committee on Immunization Practices website. ACIP members met earlier this...